Similar articles

• Risperidone long-acting injection in practice - more questions than answers?

  Taylor D. Taylor D. Acta Psychiatr Scand. 2006 Jul;114(1):1-2. doi: 10.1111/j.1600-0447.2006.00810.x. Acta Psychiatr Scand. 2006. PMID: 16774654 No abstract available.
• The risk/benefit ratio of depot neuroleptics: a Scandinavian perspective.

  Dencker SJ. Dencker SJ. J Clin Psychiatry. 1984 May;45(5 Pt 2):22-7. J Clin Psychiatry. 1984. PMID: 6143744
• [Depot antipsychotics in the year 2011].

  Knegtering H, Oolders H, Ruijsink MA, van der Moolen AE. Knegtering H, et al. Tijdschr Psychiatr. 2011;53(2):95-105. Tijdschr Psychiatr. 2011. PMID: 21319066 Review. Dutch.
• [Retrospective comparative study of treatment with delayed-action neuroleptics and neuroleptics administrated orally in long-term psychosis].

  Chambon O, Marie-Cardine M, Terra JL, Corot P. Chambon O, et al. Encephale. 1988 Jul-Aug;14(4):293-7. Encephale. 1988. PMID: 2904356 French.
• Review of the evidence for the long-term efficacy of atypical antipsychotic agents in the treatment of patients with schizophrenia and related psychoses.

  Turner MS, Stewart DW. Turner MS, et al. J Psychopharmacol. 2006 Nov;20(6 Suppl):20-37. doi: 10.1177/1359786806071243. J Psychopharmacol. 2006. PMID: 17046985 Review.